跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
NMPA
/
Rilonacept for injection
Approved
生物制品
Rilonacept for injection
KINIKSA PHARMACEUTICALS (UK), LTD.
🇨🇳 National Medical Products Administration
Approval Date
Nov 22, 2024
Approval ID
8etnWBEMK7u
Company
KINIKSA PHARMACEUTICALS (UK), LTD.
Type
生物制品
Approval Details
Approval Id
8etnWBEMK7u
Approval Number
国药准字SJ20240045
Generic Name
注射用利纳西普
Generic Name En
Rilonacept for injection
Trade Name
炎朵
Drug Type
生物制品
Dosage Form
注射剂
Strength
220mg/瓶
Reg Date
2024-11-22
Expired Date
2029-11-21
Company Name
KINIKSA PHARMACEUTICALS (UK), LTD.
Production Company Name
JUBILANT HOLLISTERSTIER LLC
Company Detail Path
/organization/kiniksa-pharmaceuticals-uk-ltd
Production Company Detail Path
/organization/jubilant-hollisterstier-llc
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Nov 22, 2024
Approval ID
8etnWBEMK7u
Type
生物制品
Back to NMPA Approvals
炎朵 - NMPA Drug Approval Details